News
Nanotein to Attend ISCT Paris 2023—Come Join Us!
Join Nanotein Technologies at this year’s International Society for Cell
Menu
Join Nanotein Technologies at this year’s International Society for Cell
The function of T cells depends on their type: effector T cell, regulatory T cell, or memory T cell. Learn how these vital immune cells defend against disease.
The function of T cells depends on their type: effector T cell, regulatory T cell, or memory T cell. Learn how these vital immune cells defend against disease.
Adoptive T-cell therapy is a promising cellular immunotherapy for cancer and other diseases. Discover its benefits, risks, and current research.
Nanotein Technologies is excited to announce we will be participating
Nanotein’s CAR-T cell infusion product has a high TSCM cell content, providing superior performance for CAR-T cell therapeutics and alleviating cytokine release syndrome (CRS) safety concerns.
Learn how immune cell markers help scientists isolate cells and enhance CAR-T therapy.
Company Summary: Nanotein Technologies is a SF Bay Area biotechnology
Curtis Hodge, CEO & Co-Founder of Nanotein, along with Zach
Subscribe to Our Newsletter
